Seelaus Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $268K | Sell |
3,230
-108
| -3% | -$8.96K | 0.24% | 131 |
|
2025
Q1 | $271K | Sell |
3,338
-325
| -9% | -$26.4K | 0.26% | 121 |
|
2024
Q4 | $330K | Sell |
3,663
-1,359
| -27% | -$122K | 0.3% | 105 |
|
2024
Q3 | $496K | Sell |
5,022
-217
| -4% | -$21.4K | 0.45% | 69 |
|
2024
Q2 | $486K | Buy |
5,239
+231
| +5% | +$21.4K | 0.49% | 63 |
|
2024
Q1 | $475K | Buy |
5,008
+40
| +0.8% | +$3.8K | 0.47% | 71 |
|
2023
Q4 | $444K | Buy |
4,968
+321
| +7% | +$28.7K | 0.43% | 81 |
|
2023
Q3 | $339K | Sell |
4,647
-475
| -9% | -$34.7K | 0.39% | 91 |
|
2023
Q2 | $426K | Buy |
5,122
+835
| +19% | +$69.4K | 0.34% | 105 |
|
2023
Q1 | $349K | Buy |
4,287
+90
| +2% | +$7.33K | 0.26% | 122 |
|
2022
Q4 | $348K | Buy |
4,197
+259
| +7% | +$21.5K | 0.26% | 127 |
|
2022
Q3 | $312K | Buy |
3,938
+20
| +0.5% | +$1.59K | 0.25% | 135 |
|
2022
Q2 | $291K | Buy |
3,918
+73
| +2% | +$5.42K | 0.22% | 144 |
|
2022
Q1 | $346K | Sell |
3,845
-2,563
| -40% | -$231K | 0.21% | 156 |
|
2021
Q4 | $717K | Buy |
6,408
+1,820
| +40% | +$204K | 0.39% | 73 |
|
2021
Q3 | $577K | Buy |
4,588
+400
| +10% | +$50.3K | 0.34% | 89 |
|
2021
Q2 | $567K | Buy |
4,188
+850
| +25% | +$115K | 0.33% | 100 |
|
2021
Q1 | $453K | Sell |
3,338
-525
| -14% | -$71.2K | 0.29% | 109 |
|
2020
Q4 | $544K | Hold |
3,863
| – | – | 0.39% | 80 |
|
2020
Q3 | $430K | Hold |
3,863
| – | – | 0.35% | 89 |
|
2020
Q2 | $432K | Sell |
3,863
-150
| -4% | -$16.8K | 0.39% | 81 |
|
2020
Q1 | $311K | Hold |
4,013
| – | – | 0.37% | 85 |
|
2019
Q4 | $382K | Sell |
4,013
-66
| -2% | -$6.28K | 0.31% | 93 |
|
2019
Q3 | $311K | Sell |
4,079
-190
| -4% | -$14.5K | 0.27% | 101 |
|
2019
Q2 | $374K | Hold |
4,269
| – | – | 0.34% | 84 |
|
2019
Q1 | $387K | Hold |
4,269
| – | – | 0.36% | 85 |
|
2018
Q4 | $306K | Buy |
4,269
+35
| +0.8% | +$2.51K | 0.33% | 89 |
|
2018
Q3 | $406K | Sell |
4,234
-750
| -15% | -$71.9K | 0.33% | 93 |
|
2018
Q2 | $474K | Sell |
4,984
-550
| -10% | -$52.3K | 0.41% | 77 |
|
2018
Q1 | $485K | Buy |
5,534
+78
| +1% | +$6.84K | 0.42% | 79 |
|
2017
Q4 | $463K | Buy |
+5,456
| New | +$463K | 0.4% | 76 |
|